RxE2 is fundamentally revolutionizing how clinical trials are conducted by utilizing, for the first time ever, community pharmacies equipped with dedicated clinical spaces, private consultation rooms, and facilities to serve as trial sites. Powered by our cutting-edge technology, we spearhead the movement toward community-based clinical trials by leveraging expansive community pharmacy access to ensure equitable access to groundbreaking treatments across every community.
Trial sponsors need partners who can flex the traditional research model, not reinvent it
The Challenge: Why Traditional Trials Fall Short
Clinical research has long operated under the “80/20 Problem,” where approximately 80% of research happens at academic medical centers (AMCs), yet 80% of healthcare treatment occurs in the community setting. This disconnect creates systemic barriers for both sponsors and patients:
The RxE2 Solution:
Unlocking Community Trust
RxE2 bridges the gap between your trials and thousands of community pharmacies. By integrating trusted community pharmacists into clinical research, we improve access, diversity, retention, and efficiency.
The Ideal Setting
20,000 Local Independent Pharmacies (US).
Access to 80,000,000 potential patients.
Pharmacists have deep knowledge of patient health, medications, and adherence patterns, supporting retention and trust.
The Community Pharmacy Site Network Infrastructure
RxE2 transforms the community pharmacy into a fully scalable clinical site, leveraging technology to ensure compliance and efficiency.
Site Functionality and Scalability
We utilize a Hub-and-spoke model where one lead pharmacy is supported by a network of referral pharmacies, allowing scale to happen within the existing network without costly closures and restarts.
As a Community Pharmacy Site, locations can offer comprehensive solutions, including:
Technological Edge and Efficiency
RxE2’s adaptive technology enables the pharmacy-based model, driven by pharmacists to improve clinical trial outcomes.
Accelerated Startup:
Accelerated activation in 8-10 Weeks (compared to an industry average of 12-36 weeks).
Compliance and Oversight:
The technology foundation is built for regulatory readiness and GCP compliance. RxE2 ensures every community site operates with the same compliance, visibility, and efficiency as a traditional clinical site, fully connected, monitored, and audit-ready.
Workflow Automation:
Automated workflows for scale, enabling recruitment, visit management, and compliance.
RxE2 Network Impact and Data
RxE2 provides the technology, processes, and support for trusted local healthcare providers to connect their patients with your trials, meeting patients where they are.
Network Scope (Execution in Motion)
0
+
Pharmacies
Activated
Activated
0
Cities (In
36 States)
36 States)
0
+
Community
Pharmacy
Sites
Pharmacy
Sites
0
+
Supported
Studies
Studies
0
M
Unique Patients
in our Data
in our Data
0
+
Patients
Contacted
Contacted
Our Community-Based Trial Services
RxE2 provides comprehensive, end-to-end services delivered by Pharmacist-led Operations. Our platform enables three core service areas that drive the success of community-based trials:
Community Access
and Recruitment
Our approach impacts the patient recruitment paradigm by meeting patients where they are. We leverage the deep trust pharmacists have with their patients to connect them with trials as care options. Services include:
Data-Driven Identification:
Automated patient identification and smart outreach based on pharmacy data.
Pharmacist-Qualified Referrals:
Pharmacist-led interviews based on IN/EX criteria and personal relationships, providing qualified referrals to study sites.
Awareness Campaigns:
Location-specific awareness campaigns using print, digital media, and pharmacist-led conversations.
End-to-End Trial
Supply Management
We simplify clinical supply strategy with a patient-centric study drug experience orchestrated by our Central Pharmacy. Approaching zero-waste supply chain and addresses adherence, compliance, and retention problems.
Direct-to-Patient (DtP) Dispensing:
Pharmacist-led dispensing of IMP, ancillary, and comparator materials.
Zero Waste:
Eliminates almost all clinical supplies waste associated with the supply chain.
Flexibility:
Addressing program needs or changes, including program & protocol, quantities / labeling, new sites, and shipment delivery locations.
Pharmacist-Led Counseling
and Site Services
Our services reduce site fatigue by providing qualified pharmacist support on study activities. The trusted pharmacist relationship sustains engagement and data quality throughout the trial.
Retention Support:
Pharmacist-led medication counseling enhances adherence and retention.
Site Support:
Conducting decentralized trial visits in private consultation rooms at the local pharmacy.
Continuous Monitoring:
Pharmacist-led medication management and counseling integrated into each visit, including real-time adherence tracking and AE reporting.
Let’s Launch your next
community-based trial together!
We encourage you to think differently.
Let’s explore how your next study can succeed through the community.